Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Cano Health, Inc. (JWS)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
   10-K10-K10-K
Cash Flows (used in) from Operating Activities:     
    Net loss  -428.4-116.7-71.1
    Adjustments to reconcile net loss to net cash (used in) from operating activities:     
        Depreciation and amortization expense  90.649.418.5
        Change in fair value of contingent consideration  -5.0-11.70.1
        Change in fair value of warrant liabilities  -72.8-82.9 
        Loss on extinguishment of debt  1.413.123.3
        Amortization of debt issuance costs  3.84.96.7
        Non-cash lease expense  6.50.7 
        Stock-based compensation, net  54.828.00.5
        Paid in kind interest expense    7.3
        Changes in operating assets and liabilities:     
            Accounts receivable, net  -106.7-15.1-30.3
            Other assets  10.1-16.6-2.8
            Prepaid expenses and other current assets  -51.7-11.8-5.4
            Interest accrued due to sellers  0.11.51.7
            Accounts payable and accrued expenses  32.633.727.3
            Other liabilities  -7.65.58.9
                Net cash (used in) provided by operating activities  -146.3-118.0-9.2
   
Cash Flows (used in) from Investing Activities:     
    Purchase of property and equipment  -49.5-34.4-12.1
    Acquisitions of subsidiaries including non-compete intangibles, net of cash acquired  -5.8-1,070.3-207.6
    Payments to sellers  -8.8-26.6-53.2
        Net cash (used in) provided by investing activities  -64.2-1,131.2-268.4
   
Cash Flows (used in) from Financing Activities:     
    Payments of long-term debt  -6.4-657.9-318.8
    Debt issuance costs  -0.1-17.4-31.1
    Proceeds from long-term debt   1,120.0664.1
    Proceeds from CS Revolving Line of Credit  109.0 9.7
    Repayments of CS Revolving Line of Credit  -25.0 -9.7
    Proceeds from insurance financing arrangements  2.51.72.9
    Payments of principal on insurance financing arrangements  -2.5-1.7-2.9
    Other   0.1 
        Net cash (used in) provided by financing activities  74.71,378.6282.2
    Net increase (decrease) in cash, cash equivalents and restricted cash  -135.8129.44.6
   
Cash, cash equivalents and restricted cash at beginning of year     
Cash, cash equivalents and restricted cash at end of period     
Supplemental cash flow information:     
    Interest paid  61.241.822.6
    Income taxes paid  0.61.2 
    Non-cash investing and financing activities:     
        Right-of-use assets obtained in exchange of lease liabilities  71.9152.6 
        Issuance of Class A common stock for acquisitions  39.364.5 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy